Modular Medical, Inc. Stock

Equities

MODD

US60785L2079

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
1.58 USD +0.64% Intraday chart for Modular Medical, Inc. -7.06% -13.19%
Sales 2024 * - Sales 2025 * 1.18M Capitalization 48.96M
Net income 2024 * -17M Net income 2025 * -16M EV / Sales 2024 * -
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 41.7 x
P/E ratio 2024 *
-1.88 x
P/E ratio 2025 *
-2.18 x
Employees 38
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.65%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.64%
1 week-7.06%
Current month-14.59%
1 month-18.97%
3 months-17.71%
6 months+58.00%
Current year-13.19%
More quotes
1 week
1.55
Extreme 1.55
1.75
1 month
1.46
Extreme 1.46
2.05
Current year
1.08
Extreme 1.08
2.22
1 year
0.84
Extreme 0.84
2.22
3 years
0.84
Extreme 0.84
19.50
5 years
0.72
Extreme 0.72
19.50
10 years
0.60
Extreme 0.6
19.50
More quotes
Managers TitleAgeSince
Founder 65 98-10-21
Chief Executive Officer 48 17-04-25
Director of Finance/CFO 55 -
Members of the board TitleAgeSince
Director/Board Member 74 21-11-28
Chief Executive Officer 48 17-04-25
Director/Board Member 69 23-07-04
More insiders
Date Price Change Volume
24-04-24 1.58 +0.64% 36,175
24-04-23 1.57 -1.88% 75,136
24-04-22 1.6 -1.84% 24,360
24-04-19 1.63 -4.12% 21,931
24-04-18 1.7 0.00% 39,438

Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT

More quotes
Modular Medical, Inc. is a development stage, medical device company. The Company is focused on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The Company, through the creation of two-part patch pump, MODD1, seeks to serve both the type 1 and type 2 diabetes markets. The Company, using its methods of insulin measurement, is able to eschew complex mechanisms and instead build a product candidate using only parts from high volume consumer electronics manufacturing lines. It provides an insulin pump, which has both basal (steady flow) and bolus (mealtime dosing) insulin disbursement. It also consists of a natural migration path to multi-chamber/multi-liquid pumps, potentially offering an array of new therapies to patients with diabetes and other conditions.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.58 USD
Average target price
4.25 USD
Spread / Average Target
+168.99%
Consensus